ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 734288 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 734288; 2) Community: the network communities that were significantly associated with the response to NSC 734288; 3) Molecule: the relationships between components within communities and NSC 734288; 4) MDR: the compounds that were significantly associated with the NSC 734288.

NSC Compound Enrichment Correlation
NSC 726432 Null 0.0401206532535671 0.10368507
NSC 72881 Null 0.0401206532535671 0.41344327
NSC 731356 2 -Amino-6-(ethylthio)-4-(furan-2-yl)pyridine-3,5-dicarbonitri le 0.0401206532535671 0.16706969
NSC 744331 (2R,11aS)-8- {2-[4-(2-{[(2R,11aS)-C2-di-Fluoro-7-Methoxy-5-oxo-2,3,5,11a-tetrahydro-1-H-benzo[e]-pyrrolo[1,2-a][1,4]diazepine-8-yl}propyl)piperazino]propoxy}-C2-di-fluoro-7-Methoxy-2,3,5,11a-tetrahyd 0.043472147060915 0.31154029
NSC 744658 6-(p-toluenesulfonylaminoethyl)diquino-1,4-thiazine 0.043472147060915 0.21622218
NSC 757306 Pyrimethamine (USAN) 0.043472147060915 0.40234504
NSC 758664 Sirolimus [USAN] 0.043472147060915 0.046012973
NSC 109451 Null 0.0434721470609156 0.18505528
NSC 123461 Ethanesulfonic acid, compd. with 4-[[3-[2-chloro-4-(4,6-diamino-2,2-dimethyl-1,3,5-triazin-1(2H)-yl)phenyl]-1-oxopropyl]amino]benzenesulfonyl fluoride (1:1) (9CI) 0.0434721470609156 0.2964121
NSC 150862 BLEOMYCIN FRACTION BLM-HPE 0.0434721470609156 0.43897771
Total:59  Current:53    [First] [Prev] [Next] [Last]